JP2023543133A5 - - Google Patents
Info
- Publication number
- JP2023543133A5 JP2023543133A5 JP2023513682A JP2023513682A JP2023543133A5 JP 2023543133 A5 JP2023543133 A5 JP 2023543133A5 JP 2023513682 A JP2023513682 A JP 2023513682A JP 2023513682 A JP2023513682 A JP 2023513682A JP 2023543133 A5 JP2023543133 A5 JP 2023543133A5
- Authority
- JP
- Japan
- Prior art keywords
- individual
- cyclodextrin
- hydroxypropyl
- cholesterol crystals
- crystals
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063071222P | 2020-08-27 | 2020-08-27 | |
| US63/071,222 | 2020-08-27 | ||
| PCT/US2021/048072 WO2022047241A1 (en) | 2020-08-27 | 2021-08-27 | Methods for the treatment of cholesterol crystal embolization with cyclodextrins |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023543133A JP2023543133A (ja) | 2023-10-13 |
| JP2023543133A5 true JP2023543133A5 (https=) | 2024-08-27 |
| JP7835735B2 JP7835735B2 (ja) | 2026-03-25 |
Family
ID=80353289
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023513682A Active JP7835735B2 (ja) | 2020-08-27 | 2021-08-27 | シクロデキストリンによるコレステロール結晶塞栓症の治療方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230330133A1 (https=) |
| EP (1) | EP4203972A4 (https=) |
| JP (1) | JP7835735B2 (https=) |
| KR (1) | KR20230096975A (https=) |
| CN (1) | CN116322643A (https=) |
| AU (1) | AU2021333902A1 (https=) |
| BR (1) | BR112023003455A2 (https=) |
| CA (1) | CA3190563A1 (https=) |
| IL (1) | IL300806A (https=) |
| MX (1) | MX2023002419A (https=) |
| WO (1) | WO2022047241A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2018517046A (ja) | 2015-06-10 | 2018-06-28 | ビテス， インコーポレイテッド | ヒドロキシプロピル−ベータ−シクロデキストリン組成物および方法 |
| JP2024509376A (ja) * | 2021-02-18 | 2024-03-01 | ベレン セラピューティクス ピー．ビー．シー． | 家族性ヘテロ接合型及びホモ接合型高コレステロール血症のシクロデキストリンによる治療方法 |
| WO2023156966A1 (en) | 2022-02-18 | 2023-08-24 | Beren Therapeutics P.B.C. | Compositions of hydroxypropyl-beta-cyclodextrin and methods of purifying the same |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4877778A (en) * | 1987-07-01 | 1989-10-31 | The Children's Medical Center Corporation | Method of enhancing lipophile transport using cyclodextrin derivatives |
| MX371073B (es) * | 2012-04-13 | 2020-01-15 | L&F Res Llc | Método para utilizar ciclodextrina. |
-
2021
- 2021-08-27 KR KR1020237010389A patent/KR20230096975A/ko not_active Withdrawn
- 2021-08-27 IL IL300806A patent/IL300806A/en unknown
- 2021-08-27 MX MX2023002419A patent/MX2023002419A/es unknown
- 2021-08-27 AU AU2021333902A patent/AU2021333902A1/en not_active Abandoned
- 2021-08-27 CN CN202180053198.8A patent/CN116322643A/zh active Pending
- 2021-08-27 BR BR112023003455A patent/BR112023003455A2/pt not_active Application Discontinuation
- 2021-08-27 EP EP21862876.6A patent/EP4203972A4/en active Pending
- 2021-08-27 US US18/043,013 patent/US20230330133A1/en active Pending
- 2021-08-27 WO PCT/US2021/048072 patent/WO2022047241A1/en not_active Ceased
- 2021-08-27 CA CA3190563A patent/CA3190563A1/en active Pending
- 2021-08-27 JP JP2023513682A patent/JP7835735B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5105687B2 (ja) | 高活性および低減された副作用を有する組換えエリスロポエチンの治療的使用 | |
| JP2023543133A5 (https=) | ||
| AU2005289621B2 (en) | Kallikrein inhibitors and uses thereof | |
| Little et al. | Combination erythropoietin-hydroxyurea therapy in sickle cell disease: NIH experience and literature review | |
| AU619926B2 (en) | Hypocholesterolemic and antiatherosclerotic uses of bis(3,5-di-tertiary-4-hydroxyphenylthio)methane | |
| JP2018510178A (ja) | 貧血治療のための組成物及び方法 | |
| Aravanis et al. | Acute myocardial infarction and cerebrovascular accident in a young girl after a viper bite. | |
| JPH06293658A (ja) | 微小血管血栓症の抑制法 | |
| Zarrabeitia et al. | A review on clinical management and pharmacological therapy on hereditary haemorrhagic telangiectasia (HHT) | |
| JP7835735B2 (ja) | シクロデキストリンによるコレステロール結晶塞栓症の治療方法 | |
| Tegenge et al. | Pharmacokinetics of antibodies during pregnancy: general pharmacokinetics and pregnancy related physiological changes (part 1) | |
| De Teresa et al. | Interaction between anticoagulants and contraceptives: an unsuspected finding. | |
| Pasternak et al. | Enhanced rate of progression of coronary artery disease following aortocoronary saphenous vein bypass surgery | |
| Hasegawa et al. | The evaluation of corticosteroid therapy in conjunction with plasma exchange in the treatment of renal cholesterol embolic disease: a report of 5 cases | |
| JP2000026300A (ja) | 血管内皮細胞保護医薬組成物 | |
| Takahashi et al. | Renal cholesterol embolic disease effectively treated with steroid pulse therapy | |
| AU2001282004B2 (en) | Method for treating unstable angina pectoris | |
| Jacob | Pulse steroids in hematologic diseases | |
| JP2002524420A (ja) | 脈管形成に有効な単位用量のｆｇｆ−２および使用方法 | |
| Brooks | Noncardiogenic pulmonary edema immediately following rapid protamine administration | |
| JP2023543132A5 (https=) | ||
| JP2008007512A (ja) | 動脈狭窄の減弱方法 | |
| CN114619041B (zh) | 一种铈修饰金纳米团簇及其制备方法、应用 | |
| Pacchiarini et al. | Atheroembolic renal disease associated with dabigatran overdose | |
| CN100548303C (zh) | 包含美拉加群和地塞米松的组合产品 |